BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35086136)

  • 21. Lenalidomide efficacy in activated B-cell-like subtype diffuse large B-cell lymphoma is dependent upon IRF4 and cereblon expression.
    Zhang LH; Kosek J; Wang M; Heise C; Schafer PH; Chopra R
    Br J Haematol; 2013 Feb; 160(4):487-502. PubMed ID: 23252516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD37 in B Cell Derived Tumors-More than Just a Docking Point for Monoclonal Antibodies.
    Bobrowicz M; Kubacz M; Slusarczyk A; Winiarska M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
    Hou Y; Zi J; Liu S; Ge Q; Ge Z
    Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysregulated MDR1 by PRDM1/Blimp1 Is Involved in the Doxorubicin Resistance of Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.
    Qing K; Jin Z; Xu Z; Wang W; Li X; Zhang Y; Wang L; Zhu H; Xiang R; Wu S; Li R; Jiang G; Xue K; Li J
    Chemotherapy; 2022; 67(1):12-23. PubMed ID: 34844236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
    Wong KK; Gascoyne DM; Brown PJ; Soilleux EJ; Snell C; Chen H; Lyne L; Lawrie CH; Gascoyne RD; Pedersen LM; Møller MB; Pulford K; Murphy D; Green TM; Banham AH
    Leukemia; 2014 Feb; 28(2):362-72. PubMed ID: 23884370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
    Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
    BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon regulatory factor 8 (IRF8) interacts with the B cell lymphoma 6 (BCL6) corepressor BCOR.
    Yoon J; Feng X; Kim YS; Shin DM; Hatzi K; Wang H; Morse HC
    J Biol Chem; 2014 Dec; 289(49):34250-7. PubMed ID: 25331958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
    Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
    Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p63 protein expression in high risk diffuse large B-cell lymphoma.
    Hallack Neto AE; Siqueira SA; Dulley FL; Ruiz MA; Chamone DA; Pereira J
    J Clin Pathol; 2009 Jan; 62(1):77-9. PubMed ID: 19103865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and characterization of the Eµ-Irf8 mouse model.
    Qiu Z; Holder KN; Lin AP; Myers J; Jiang S; Gorena KM; Kinney MC; Aguiar RCT
    Cancer Genet; 2020 Jul; 245():6-16. PubMed ID: 32535543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
    Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
    Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon Regulatory Factor 8 (IRF8) Impairs Induction of Interferon Induced with Tetratricopeptide Repeat Motif (IFIT) Gene Family Members.
    White CL; Kessler PM; Dickerman BK; Ozato K; Sen GC
    J Biol Chem; 2016 Jun; 291(26):13535-45. PubMed ID: 27137933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma.
    Huang Q; Zhang F; Fu H; Shen J
    Epigenetics; 2021 Jan; 16(1):28-44. PubMed ID: 32600091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-6 is essential for glomerular immunoglobulin A deposition and the development of renal pathology in Cd37-deficient mice.
    Rops ALWMM; Jansen E; van der Schaaf A; Pieterse E; Rother N; Hofstra J; Dijkman HBPM; van de Logt AE; Wetzels J; van der Vlag J; van Spriel AB
    Kidney Int; 2018 Jun; 93(6):1356-1366. PubMed ID: 29551516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals.
    Lapalombella R; Yeh YY; Wang L; Ramanunni A; Rafiq S; Jha S; Staubli J; Lucas DM; Mani R; Herman SEM; Johnson AJ; Lozanski A; Andritsos L; Jones J; Flynn JM; Lannutti B; Thompson P; Algate P; Stromatt S; Jarjoura D; Mo X; Wang D; Chen CS; Lozanski G; Heerema NA; Tridandapani S; Freitas MA; Muthusamy N; Byrd JC
    Cancer Cell; 2012 May; 21(5):694-708. PubMed ID: 22624718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The tetraspanin protein CD37 regulates IgA responses and anti-fungal immunity.
    van Spriel AB; Sofi M; Gartlan KH; van der Schaaf A; Verschueren I; Torensma R; Raymakers RA; Loveland BE; Netea MG; Adema GJ; Wright MD; Figdor CG
    PLoS Pathog; 2009 Mar; 5(3):e1000338. PubMed ID: 19282981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.
    Deckert J; Park PU; Chicklas S; Yi Y; Li M; Lai KC; Mayo MF; Carrigan CN; Erickson HK; Pinkas J; Lutz RJ; Chittenden T; Lambert JM
    Blood; 2013 Nov; 122(20):3500-10. PubMed ID: 24002446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic-Based Analysis of Hypoxia- and Physioxia-Responsive Proteins and Pathways in Diffuse Large B-Cell Lymphoma.
    Duś-Szachniewicz K; Gdesz-Birula K; Zduniak K; Wiśniewski JR
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IRF8 governs expression of genes involved in innate and adaptive immunity in human and mouse germinal center B cells.
    Shin DM; Lee CH; Morse HC
    PLoS One; 2011; 6(11):e27384. PubMed ID: 22096565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.